Life after pancreas transplantation: Reversal of diabetic lesions

Current Opinion in Organ Transplantation

Volumn 19, Issue 1, 2014, Pages 73-79

  Dunn, Ty B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

diabetic complications; long term outcome; pancreas transplantation

Indexed keywords

EID: 84895900502     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000045     Document Type: Review

References (84)

1. Smets YF, Westendorp RG, van der Pijl JW, et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353:1915-1919.
2. Tyde'n G, Bolinder J, Solders G, et al. Improved survival in patients with insulindependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999; 67:645-648.
3. Mohan P, Safi K, Little DM, et al. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 2003; 90:1137-1141.
4. Sollinger HW, Odorico JS, Becker YT, et al. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009; 250:618-630.
5. Wiseman AC. Pancreas transplant options for patients with type 1 diabetes mellitus and chronic kidney disease: simultaneous pancreas kidney or pancreas after kidney? Curr Opin Organ Transplant 2012; 17:80-86.
6. Meier-Kriesche HU, Stegall MD. Should we be performing pancreas transplants? Am J Transplant 2004; 4:1935-1936.
7. Gruessner RWG, Sutherland DER, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004; 4:2018-2026.
8. Van Dellen D, Worthington J, Mitu-Pretorian OM, et al. Mortality in diabetes: pancreas transplantation is associated with significant survival benefit. Nephrol Dial Transplant 2013; 28:1315-1322.
9. Navarro X, Kennedy W, Loewenson RB, Sutherland DER. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990; 39:802-806.
10. Gruessner AC. 2011 update on pancreas transplantation: comprehensive trend analysis of 25 000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud 2011; 8:6-16.
11. .Gruessner AC, Sutherland DER, Gruessner RWG. Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant 2012; 17:100-105.
12. Wai PY, Sollinger HW. Long-term outcomes after simultaneous pancreaskidney transplant. Curr Opin Organ Transplant 2011; 16:128-134.
13. The Diabetes Control Complications Trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
14. .Boggi U, Rosati CM, Marchetti P. Follow-up of secondary diabetic complications after pancreas transplantation. Curr Opin Organ Transplant 2013; 18:102-110.
15. Ceriello A. The emerging challenge in diabetes: the 'metabolic memory'. Vascul Pharmacol 2012; 57:133-138.
16. Tooke JE. Microvasculature in diabetes. Cardiovasc Res 1996; 32:764-771.
17. Zou M, Shi C, Cohen R. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 2002; 51:198-203.
18. Cohen RA. Role of nitric oxide in diabetic complications. Am J Ther 2005; 12:499-502.
19. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006; 27:552-558.
20. Kowluru RA, Kanwar M, Kennedy A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res 2007; 2007:21976.
21. Madsen-Bouterse S, Mohammad G, Kanwar M, Kowluru R. Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression. Antioxid Redox Signal 2010; 13:797-805.
22. The DCCT/EDIC Reseach Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653.
23. Santos JM, Kowluru RA. Impaired transport of mitochondrial transcription factor A (TFAM) and the metabolic memory phenomenon associated with the progression of diabetic retinopathy. Diabetes Metab Res Rev 2013; 29:204- 213.
24. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404:787-790.
25. Takahashi H, Tran P, LeRoy E, et al. D-Glyceraldehyde causes production of intracellular peroxide in pancreatic islets, oxidative stress, and defective beta cell function via nonmitochondrial pathways. J Biol Chem 2004; 279:37316- 37323.
26. Wilkin TJ. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obes 2009; 33:716-726.
27. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320:1161-1165.
28. Fourlanos S, Dotta F, Greenbaum CJ, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005; 48:2206-2212.
29. Intine RV, Sarras MP. Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms. Curr Diab Rep 2012; 12:551-559.
30. Goldenberg R, Cheng A. Use of glycated hemoglobin (A1c) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diabetes 2011; 35:247-249.
31. Pfeifer M, Weinberg CR, Cook DL, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 1984; 7:447-453.
32. Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57:1349-1354.
33. Schisano B, Tripathi G, McGee K, et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia 2011; 54:1219-1226.
34. Borg R, Kuenen JC, Carstensen B, et al. HbA(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1CDerived Average Glucose (ADAG) study. Diabetologia 2011; 54:69-72.
35. Orlando G, Stratta RJ, Light J. Pancreas transplantation for type 2 diabetes mellitus. Curr Opin Organ Transplant 2011; 16:110-115.
36. Sampaio MS, Kuo H-T, Bunnapradist S. Outcomes of simultaneous pancreaskidney transplantation in type 2 diabetic recipients. Clin J Am Soc Nephrol 2011; 6:1198-1206.
37. Margreiter C, Resch T, Oberhuber R, et al. Combined pancreas-kidney transplantation for patients with end-stage nephropathy caused by type-2 diabetes mellitus. Transplantation 2013; 95:1030-1036.
38. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl 1):S62-S69.
39. Demartines N, Schiesser M, Clavien P-A. An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone. Am J Transplant 2005; 5:2688-2697.
40. Augustine T. Simultaneous pancreas and kidney transplantation in diabetes with renal failure: the gold standard? J Ren Care 2012; 38 (Suppl 1):115-124.
41. Currie CJ, Poole CD, Woehl A, et al. The financial costs of healthcare treatment for people with type 1 or type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 2007; 24:187-194.
42. Dall TM, Mann SE, Zhang Y, et al. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul Health Manag 2009; 12:103-110.
43. American Diabetes Association. Economic costs of diabetes in the U.S in 2012. Diabetes Care 2013; 36:1033-1046.
44. Franciosi M, Lucisano G,Amoretti R, et al.Costs of treatment andcomplications of adult type 1 diabetes. Nutr Metab Cardiovasc Dis 2013; 23:606-611.
45. Sutherland DE, Kendall DM, Moudry KC, et al. Pancreas transplantation in nonuremic, type I diabetic recipients. Surgery 1988; 104:453-464.
46. Nakache R, Tyde'n G, Groth CG. Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes 1989; 38 (Suppl 1):40-42.
47. Gross CR, Limwattananon C, Matthees BJ. Quality of life after pancreas transplantation: a review. Clin Transplant 1998; 12:351-361.
48. Douzdjian V, Ferrara D, Silvestri G. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model. Am J Kidney Dis 1998; 31:794-802.
49. Kiebert GM, Van Oosterhout EC, Van Bronswijk H, et al. Quality of life after combined kidney-pancreas or kidney transplantation in diabetic patients with end-stage renal disease. Clin Transplant 1994; 8:239-245.
50. Nathan DM, Lachin J, Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003; 348:2294-2303.
51. Humar A, Ramcharan T, Kandaswamy R, et al. Pancreas after kidney transplants. Am J Surg 2001; 182:155-161.
52. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001; 233:463-501.
53. Ziaja J, Bozek-Pajak D, Kowalik A, et al. Impact of pancreas transplantation on the quality of life of diabetic renal transplant recipients. Transplant Proc 2009; 41:3156-3158.
54. Landgraf R. Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 1996; 39:1415-1424.
55. White SA, Shaw JA, Sutherland DER. Pancreas transplantation. Lancet 2009; 373:1808-1817.
56. The DCCT/EDIC Reseach Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011; 365:2366-2376.
57. Ulbig M, Kampik A, Landgraf R, Land W. The influence of combined pancreatic and renal transplantation on advanced diabetic retinopathy. Transplant Proc 1987; 19:3554-3556.
58. Ramsay RC, Goetz FC, Sutherland DE, et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 1988; 318:208-214.
59. Ko? nigsrainer A, Miller K, Steurer W, et al. Does pancreas transplantation influence the course of diabetic retinopathy? Diabetologia 1991; 34 (Suppl 1): S86-S88.
60. Giannarelli R, Coppelli A, Sartini M, et al. Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl Int 2005; 18:619-622.
61. Giannarelli R, Coppelli A, Sartini MS, et al. Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients. Diabetologia 2006; 49:2977-2982.
62. Fioretto P, Mauer SM, Bilous RW, et al. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 1993; 342:1193-1196.
63. Fioretto P, Steffes M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339:69-75.
64. Fioretto P, Sutherland DER, Najafian B, Mauer M. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int 2006; 69:907-912.
65. Mauer M, Fioretto P. Pancreas transplantation and reversal of diabetic nephropathy lesions. Med Clin North Am 2013; 97:109-114.
66. Kennedy W, Navarro X, Frederick C, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322:1031-1037.
67. Solders G, Tyde'n G, Persson A, Groth C. Improvement of nerve conduction in diabetic neuropathy: a follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 1992; 8:7-12.
68. Hathaway D, Abell T, Cardoso S, et al. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-Alone transplantation and the correlation with quality of life. Transplantation 1994; 57:816-822.
69. Kendall DM, Rooney DP, Smets YF, et al. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 1997; 46:249-257.
70. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997; 42:727-736.
71. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Investig 2011; 2:18-32.
72. Orestes P, Osuru HP, McIntire WE, et al. Reversal of neuropathic pain in diabetes by targeting glycosylation of CaV3.2 T-type calcium channels. Diabetes 2013; 62:3828-3838.
73. Tavakoli M, Mitu-Pretorian M, Petropoulos IN, et al. Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 2013; 62:254-260.
74. Parving H, Viberti G, Keen H. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983; 32:943-949.
75. Jukema JW, Smets YFC, Van Der Pijl JW, et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002; 25:906-911.
76. Boone MI, Farber ME, Jovanovic-Peterson L, Peterson CM. Increased retinal vascular tortuosity in gestational diabetes mellitus. Ophthalmology 1989; 96:251-254.
77. .Djaberi R, Schuijf JD, De Koning EJ, et al. Noninvasive assessment of microcirculation by sidestream dark field imaging as a marker of coronary artery disease in diabetes. Diabetes Vasc Dis Res 2013; 10:123-134.
78. .Khairoun M, De Koning EJP, Van Den Berg BM, et al. Microvascular damage in type 1 diabetic patients is reversed in the first year after simultaneous pancreas-kidney transplantation. Am J Transplant 2013; 13:1272-1281.
79. Fiorina P, La Rocca E, Venturini M, et al. Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 2001; 50:496-501.
80. Biesenbach G, Ko? nigsrainer A, Gross C, Margreiter R. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone. Transpl Int 2005; 18:1054-1060.
81. Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 2007; 30:2608-2612.
82. Folli F, Guzzi V, Perego L, et al. Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation. PLoS One 2010; 5:e9923.
83. Intine RV, Olsen AS, Sarras MP. A zebrafish model of diabetes mellitus and metabolic memory. J Vis Exp 2013; e50232.
84. Pichaiwong W, Hudkins KL, Wietecha T, et al. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol 2013; 24:1088-1102.